Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01596751 |
|---|---|
| Brief Title: | Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer |
| First Submitted : | May 7, 2012 |
| First Submitted that Met QC Criteria : | May 9, 2012 |
| First Posted : | May 11, 2012 (Estimate) |
| Results First Submitted : | April 1, 2020 |
| Results First Submitted that Met QC Criteria : | May 1, 2020 |
| Results First Posted : | May 14, 2020 |
| Last Update Submitted that Met QC Criteria : | July 2, 2020 |
| Last Update Posted : | July 17, 2020 |